4:31 pm Biomarin Pharm confirms FDA approval for VIMIZIM (elosulfase alfa) for the treatment of patients with Morquio A syndrome
View todays social media effects on BMRN
View the latest stocks trending across Twitter. Click to view dashboard
View todays social media effects on BMRN
View the latest stocks trending across Twitter. Click to view dashboard